Search results
Merck beats earnings expectations, raises outlook on strong Keytruda and vaccine sales
CNBC· 3 days agoMerck on Thursday reported first-quarter revenue and adjusted earnings that topped expectations as...
Merck KGaA (ETR:MRK) Is Due To Pay A Dividend Of €2.20
Simply Wall St. via Yahoo Finance· 10 hours agoThe board of Merck KGaA (ETR:MRK) has announced that it will pay a dividend of €2.20 per share on...
Merck & Co., Inc. (NYSE:MRK) Just Released Its First-Quarter Earnings: Here's What Analysts Think
Simply Wall St. via Yahoo Finance· 1 day agoMerck & Co., Inc. (NYSE:MRK) just released its quarterly report and things are looking bullish. The...
Merck raises 2024 profit forecast on strong cancer, HPV drugs sales
Reuters· 3 days agoThe New Jersey-based drugmaker said it expected earnings of $8.53 and $8.65 per share, up from its...
Merck Stock Jumps After Dow Jones Stalwart Rides Its Cancer 'Star' To Another Quarterly Beat
Investor's Business Daily· 3 days agoMerck stock popped Thursday after the Dow Jones stalwart topped Wall Street's first-quarter views on...
Merck’s first-quarter results beat expectations amid healthy vaccine-sales growth
Market Watch· 3 days agoMerck & Co. Inc. on Thursday reported first-quarter results that beat analysts’ expectations amid...
Merck stock target raised on strong Q1 results By Investing.com
Investing.com· 2 days agoOn Friday, Wells Fargo adjusted its outlook on shares of pharmaceutical giant Merck & Co., Inc....
Merck stock gains on Q1 2024 beat (NYSE:MRK)
Seeking Alpha· 3 days agoMerck (MRK) stock gains as the company posts better than expected Q1 2024 financials with strong sales growth from its cancer medicine Keytruda. Read...
How Should You Play Merck (MRK) Stock Ahead of Q1 Earnings?
Zacks· 7 days agoFree Report) will report first-quarter 2024 results on Apr 25, before market open. In the last...
Merck (MRK) Q1 Earnings Top, Cancer Drug Keytruda Boosts Sales
Zacks· 4 days agoFree Report) reported adjusted earnings of $2.07 per share for first-quarter 2024, beating the Zacks Consensus Estimate of $1.94. Earnings rose 48% year over year on a reported basis and 54% ...